Saul Kato
individual
About
Saul Kato is a neuroscientist and entrepreneur affiliated with UCSF, where QB3 describes him as an associate professor of neurology. He co-founded System1 Biosciences and later co-founded Herophilus, which his lab site says was acquired by Roche in 2023. His profile spans academic neuroscience, brain organoid drug-discovery platforms, and machine-learning-enabled neurobiology research.
Areas of interest
neurosciencecomputational neurosciencemachine learningartificial intelligenceneurodevelopmental disordersautismschizophreniabrain organoidsneurotherapeuticsmicroscopy and neural imaging